Drug intelligence / Profile preview

carboxylated zinc phthalocyanine

Development stage
Preclinical
Lead developer
Shimane University
Modality
Small Molecules
Administration
Intraperitoneal
01

Overview

Carboxylated zinc phthalocyanine is a water-soluble, macrocyclic metallophthalocyanine compound with near-infrared optical properties being investigated as a therapeutic agent for Alzheimer's disease. Developed by researchers at Shimane University, the compound acts as an amyloid-beta (Aβ) aggregation inhibitor. It physically binds to Aβ peptides, decreasing their hydrophobicity and destabilizing pre-formed fibrils, which prevents the formation of neurotoxic oligomers and fibrils. In preclinical mouse models of Alzheimer's disease, treatment with carboxylated zinc phthalocyanine significantly reduced brain amyloid-beta deposition, decreased glial activation (astrocytes and microglia), increased vessel density, and improved cognitive performance without showing liver or kidney toxicity.

Other names
carboxylated Zn-phthalocyanineocta-carboxyl substituted zinc phthalocyaninezinc octacarboxyphthalocyanineZnPc(COOH)8ZnPc(COONa)8ZnPcOC
02

Targets

Aβ (Amyloid-beta peptides and aggregates)

Beyond the preview

Go deeper on carboxylated zinc phthalocyanine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on carboxylated zinc phthalocyanine.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call